SG11201609286VA - Antibacterial quinazoline-4(3h)-one derivatives - Google Patents
Antibacterial quinazoline-4(3h)-one derivativesInfo
- Publication number
- SG11201609286VA SG11201609286VA SG11201609286VA SG11201609286VA SG11201609286VA SG 11201609286V A SG11201609286V A SG 11201609286VA SG 11201609286V A SG11201609286V A SG 11201609286VA SG 11201609286V A SG11201609286V A SG 11201609286VA SG 11201609286V A SG11201609286V A SG 11201609286VA
- Authority
- SG
- Singapore
- Prior art keywords
- derivatives
- quinazoline
- antibacterial
- antibacterial quinazoline
- Prior art date
Links
- QMNUDYFKZYBWQX-UHFFFAOYSA-N 1H-quinazolin-4-one Chemical class C1=CC=C2C(=O)N=CNC2=C1 QMNUDYFKZYBWQX-UHFFFAOYSA-N 0.000 title 1
- 230000000844 anti-bacterial effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14168718 | 2014-05-16 | ||
| PCT/EP2015/060653 WO2015173329A1 (en) | 2014-05-16 | 2015-05-13 | Antibacterial quinazoline-4(3h)-one derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201609286VA true SG11201609286VA (en) | 2016-12-29 |
Family
ID=50731968
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201609286VA SG11201609286VA (en) | 2014-05-16 | 2015-05-13 | Antibacterial quinazoline-4(3h)-one derivatives |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US9796686B2 (en) |
| EP (1) | EP3143007B1 (en) |
| JP (1) | JP2017515906A (en) |
| KR (1) | KR20170005105A (en) |
| CN (1) | CN106458931A (en) |
| AR (1) | AR100428A1 (en) |
| AU (1) | AU2015261540A1 (en) |
| BR (1) | BR112016026787A8 (en) |
| CA (1) | CA2948077A1 (en) |
| CL (1) | CL2016002918A1 (en) |
| EA (1) | EA201692305A1 (en) |
| ES (1) | ES2687040T3 (en) |
| IL (1) | IL248922A0 (en) |
| MX (1) | MX2016014989A (en) |
| PH (1) | PH12016502253A1 (en) |
| SG (1) | SG11201609286VA (en) |
| TW (1) | TW201625559A (en) |
| WO (1) | WO2015173329A1 (en) |
| ZA (1) | ZA201608680B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR097617A1 (en) | 2013-09-13 | 2016-04-06 | Actelion Pharmaceuticals Ltd | ANTIBACTERIAL DERIVATIVES OF 2H-INDAZOL |
| MA39189A1 (en) | 2013-12-19 | 2017-06-30 | Actelion Pharmaceuticals Ltd | Derivatives of 1h-indazole and 1h-indole antibacterials |
| AR099612A1 (en) | 2014-03-04 | 2016-08-03 | Actelion Pharmaceuticals Ltd | ANTIBACTERIAL DERIVATIVES OF 1,2-DIHIDRO-3H-PIRROLO [1,2-C] IMIDAZOL-3-ONA |
| AR105646A1 (en) * | 2015-08-11 | 2017-10-25 | Actelion Pharmaceuticals Ltd | ANTIBACTERIAL AGENTS OF 1,2-DIHIDRO-3H-PIRROLO [1,2-C] IMIDAZOL-3-ONA SUBSTITUTED |
| JP2018531902A (en) * | 2015-08-28 | 2018-11-01 | イドーシア ファーマシューティカルズ リミテッドＩｄｏｒｓｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ | Antibacterial condensed pyrrolidin-2-one derivatives |
| AR105889A1 (en) | 2015-09-03 | 2017-11-22 | Actelion Pharmaceuticals Ltd | ANTIBACTERIAL COMPOUNDS 1,2-DIHIDRO-3H-PIRROLO [1,2-C] IMIDAZOL-3-ONA SUBSTITUTED |
| JP2019501896A (en) * | 2015-12-08 | 2019-01-24 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ | Substituted benzazinones as antibacterial compounds |
| AU2017242027B2 (en) | 2016-04-01 | 2020-10-08 | Recurium Ip Holdings, Llc | Estrogen receptor modulators |
| PT3519387T (en) * | 2016-09-28 | 2021-09-28 | Dong A St Co Ltd | Tetrahydropyridine derivatives and their use as antibacterial agents |
| BR112022002138A2 (en) | 2019-08-06 | 2022-04-19 | Recurium Ip Holdings Llc | Estrogen receptor modulators for treatment of mutants |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA58543C2 (en) | 1997-02-27 | 2003-08-15 | Амерікан Ціанамід Компані | N-hydroxy-2-(alkyl-, aryl-, or heteroarylsulfanyl, -sulfinyl or sulfonyl)-3-substituted alkyls, aryls or heteroarylamides as inhibitors of matrix metalloproteinases |
| TWI338685B (en) | 2002-03-13 | 2011-03-11 | Array Biopharma Inc | N3 alkylated benzimid azole derivatives as mek inhibitors |
| CA2691987C (en) * | 2007-06-12 | 2016-08-16 | Achaogen, Inc. | Antibacterial agents |
| WO2010024356A1 (en) | 2008-08-27 | 2010-03-04 | 大正製薬株式会社 | Novel hydroxamic acid derivative having naphthyridine-n-oxide |
| JP2012504556A (en) | 2008-10-03 | 2012-02-23 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Viral polymerase inhibitor |
| DE102008044132A1 (en) | 2008-11-27 | 2010-06-02 | BSH Bosch und Siemens Hausgeräte GmbH | Refrigerating appliance with double-sided door |
| US8372807B2 (en) | 2009-05-20 | 2013-02-12 | Ardea Biosciences, Inc. | Methods of modulating uric acid levels |
| JP5671545B2 (en) | 2009-10-13 | 2015-02-18 | ファイザー・インク | C-bonded hydroxamic acid derivatives useful as antibacterial agents |
| CA2782453C (en) * | 2009-12-16 | 2015-11-24 | Matthew Frank Brown | N-linked hydroxamic acid derivatives useful as antibacterial agents |
| US8765773B2 (en) | 2010-10-18 | 2014-07-01 | Millennium Pharmaceuticals, Inc. | Substituted hydroxamic acids and uses thereof |
| KR20140023869A (en) | 2010-11-10 | 2014-02-27 | 아카오젠, 인코포레이티드 | Hydroxamic acid derivatives and their use in the treatment of bacterial infections |
| WO2012093809A2 (en) | 2011-01-03 | 2012-07-12 | Hanmi Pharm Co., Ltd. | New bicyclic compound for modulating g protein-coupled receptors |
| PH12013501780A1 (en) * | 2011-03-07 | 2019-07-03 | Pfizer | Fluoro-pyridinone derivatives useful as antibacterial agents |
| KR20130140164A (en) | 2011-04-08 | 2013-12-23 | 화이자 인코포레이티드 | Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents |
| SG193367A1 (en) | 2011-04-08 | 2013-10-30 | Pfizer | Isoxazole derivatives useful as antibacterial agents |
| US9260452B2 (en) | 2011-06-08 | 2016-02-16 | Sunovion Pharmaceuticals Inc. | Metabotrophic glutamate receptor 5 modulators and methods of use thereof |
| WO2013170030A1 (en) | 2012-05-09 | 2013-11-14 | Achaogen, Inc. | Antibacterial agents |
| EP2847168A1 (en) * | 2012-05-10 | 2015-03-18 | Achaogen, Inc. | Antibacterial agents |
| JP6458270B2 (en) | 2013-08-16 | 2019-01-30 | デューク ユニバーシティ | Substituted hydroxamic acid compounds |
| AR097617A1 (en) | 2013-09-13 | 2016-04-06 | Actelion Pharmaceuticals Ltd | ANTIBACTERIAL DERIVATIVES OF 2H-INDAZOL |
| MA39189A1 (en) | 2013-12-19 | 2017-06-30 | Actelion Pharmaceuticals Ltd | Derivatives of 1h-indazole and 1h-indole antibacterials |
| AR099612A1 (en) | 2014-03-04 | 2016-08-03 | Actelion Pharmaceuticals Ltd | ANTIBACTERIAL DERIVATIVES OF 1,2-DIHIDRO-3H-PIRROLO [1,2-C] IMIDAZOL-3-ONA |
-
2015
- 2015-05-13 AU AU2015261540A patent/AU2015261540A1/en not_active Abandoned
- 2015-05-13 ES ES15722212.6T patent/ES2687040T3/en active Active
- 2015-05-13 CA CA2948077A patent/CA2948077A1/en not_active Abandoned
- 2015-05-13 EP EP15722212.6A patent/EP3143007B1/en not_active Not-in-force
- 2015-05-13 SG SG11201609286VA patent/SG11201609286VA/en unknown
- 2015-05-13 US US15/311,758 patent/US9796686B2/en not_active Expired - Fee Related
- 2015-05-13 MX MX2016014989A patent/MX2016014989A/en unknown
- 2015-05-13 AR ARP150101482A patent/AR100428A1/en unknown
- 2015-05-13 EA EA201692305A patent/EA201692305A1/en unknown
- 2015-05-13 CN CN201580024307.8A patent/CN106458931A/en active Pending
- 2015-05-13 BR BR112016026787A patent/BR112016026787A8/en not_active Application Discontinuation
- 2015-05-13 WO PCT/EP2015/060653 patent/WO2015173329A1/en not_active Ceased
- 2015-05-13 JP JP2017512426A patent/JP2017515906A/en not_active Ceased
- 2015-05-13 KR KR1020167035088A patent/KR20170005105A/en not_active Withdrawn
- 2015-05-15 TW TW104115665A patent/TW201625559A/en unknown
-
2016
- 2016-11-11 PH PH12016502253A patent/PH12016502253A1/en unknown
- 2016-11-13 IL IL248922A patent/IL248922A0/en unknown
- 2016-11-16 CL CL2016002918A patent/CL2016002918A1/en unknown
- 2016-12-15 ZA ZA2016/08680A patent/ZA201608680B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR100428A1 (en) | 2016-10-05 |
| WO2015173329A1 (en) | 2015-11-19 |
| BR112016026787A2 (en) | 2017-08-15 |
| IL248922A0 (en) | 2017-01-31 |
| TW201625559A (en) | 2016-07-16 |
| EP3143007A1 (en) | 2017-03-22 |
| EP3143007B1 (en) | 2018-07-11 |
| EA201692305A1 (en) | 2017-05-31 |
| US20170081292A1 (en) | 2017-03-23 |
| KR20170005105A (en) | 2017-01-11 |
| AU2015261540A1 (en) | 2017-01-12 |
| CN106458931A (en) | 2017-02-22 |
| PH12016502253A1 (en) | 2017-01-16 |
| ZA201608680B (en) | 2018-11-28 |
| ES2687040T3 (en) | 2018-10-23 |
| JP2017515906A (en) | 2017-06-15 |
| BR112016026787A8 (en) | 2017-12-26 |
| CA2948077A1 (en) | 2015-11-19 |
| MX2016014989A (en) | 2017-03-31 |
| CL2016002918A1 (en) | 2017-04-07 |
| US9796686B2 (en) | 2017-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201800826B (en) | Substituted oxopyridine derivatives | |
| IL253588A0 (en) | Bicyclic quinazolinone derivatives | |
| ZA201608680B (en) | Antibacterial quinazoline-4(3h)-one derivatives | |
| IL248005B (en) | Macrocylic pyrimidine derivatives | |
| IL253381B (en) | 9h-pyrrolo-dipyridine derivatives | |
| PL3359543T3 (en) | Cucurbituril derivatives | |
| SG11201609205WA (en) | Heterocyclyl-butanamide derivatives | |
| IL244252A0 (en) | Otoscope with controlled illumination | |
| PL3164393T3 (en) | Flavagline derivatives | |
| HUE050450T2 (en) | Fluoroalkylfluorene derivatives | |
| IL248773A0 (en) | Naphthyridinedione derivatives | |
| GB201405462D0 (en) | Zonal optical elements | |
| GB201801510D0 (en) | Exterior unit | |
| PL3529570T3 (en) | Telemetric fitting | |
| IL252269A0 (en) | Antibacterial benzothiazole derivatives | |
| IL251005B (en) | Pyrido-oxazinone derivatives | |
| IL248629B (en) | Cycloalkyl-linked diheterocycle derivatives | |
| IL250405A0 (en) | Antibacterial sideromycins | |
| PL3119744T3 (en) | 2-cyano-3-cyclopropyl-3-hydroxy-n-aryl-thioacrylamide derivatives | |
| GB201704471D0 (en) | Custom kiosk | |
| HK1235397A1 (en) | Antibacterial quinazoline-4(3h)-one derivatives | |
| PT3319956T (en) | Substituted oxopyridine derivatives | |
| TWM489867U (en) | Antibiotic metal water curtain |